Skip to Content
Merck
CN
  • Triad3a induces the degradation of early necrosome to limit RipK1-dependent cytokine production and necroptosis.

Triad3a induces the degradation of early necrosome to limit RipK1-dependent cytokine production and necroptosis.

Cell death & disease (2018-05-24)
Norah A Alturki, Scott McComb, Ardeshir Ariana, Dikchha Rijal, Robert G Korneluk, Shao-Cong Sun, Emad Alnemri, Subash Sad
ABSTRACT

Understanding the molecular signaling in programmed cell death is vital to a practical understanding of inflammation and immune cell function. Here we identify a previously unrecognized mechanism that functions to downregulate the necrosome, a central signaling complex involved in inflammation and necroptosis. We show that RipK1 associates with RipK3 in an early necrosome, independent of RipK3 phosphorylation and MLKL-induced necroptotic death. We find that formation of the early necrosome activates K48-ubiquitin-dependent proteasomal degradation of RipK1, Caspase-8, and other necrosomal proteins. Our results reveal that the E3-ubiquitin ligase Triad3a promotes this negative feedback loop independently of typical RipK1 ubiquitin editing enzymes, cIAPs, A20, or CYLD. Finally, we show that Triad3a-dependent necrosomal degradation limits necroptosis and production of inflammatory cytokines. These results reveal a new mechanism of shutting off necrosome signaling and may pave the way to new strategies for therapeutic manipulation of inflammatory responses.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lactacystin, ≥90% (HPLC)
Sigma-Aldrich
Lipopolysaccharides from Escherichia coli O111:B4, purified by ion-exchange chromatography, TLR ligand tested
Sigma-Aldrich
Hydroxychloroquine sulfate, ≥98% (HPLC), powder
Sigma-Aldrich
Z-Leu-Leu-Leu-al, ≥90% (HPLC)
Roche
cOmplete, EDTA-free Protease Inhibitor Cocktail, Tablets provided in EASYpacks
Sigma-Aldrich
Anti-MLKL Antibody, clone 3H1, clone 3H1, from rat
Sigma-Aldrich
MISSION® esiRNA, targeting human CYLD